AGENUS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
AGENUS INC (AGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.29 million shares for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2016-05-09
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-03-31 was 1.29M shares, a 28.25% decline year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-12-31 was 237.40K shares, a 29.59% increase year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-09-30 was 397.70K shares, a 236.75% increase year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-06-30 was 391.60K shares, a 86.02% decline year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 2.82M shares, a 13.87% decline from fiscal 2014.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 3.28M shares, a 121.05% increase from fiscal 2013.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 1.48M shares, a 46.56% increase from fiscal 2012.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 1.01M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2016-03-31 | 1.29M shares 10-Q · filed 2016-05-09 | 1.53M shares derived: sum of 2 quarters · filed 2016-05-09 | 1.92M shares derived: sum of 3 quarters · filed 2016-05-09 | 2.32M shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 237.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 635.10K shares derived: sum of 2 quarters · filed 2016-03-15 | 1.03M shares derived: sum of 3 quarters · filed 2016-03-15 | 2.82M shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 397.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | 789.30K shares derived: sum of 2 quarters · filed 2015-11-04 | 2.59M shares 10-Q · filed 2015-11-04 | 2.77M shares derived: sum of 4 quarters · filed 2015-11-04 |
| 2015-06-30 | 391.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | 2.19M shares 10-Q · filed 2015-08-03 | 2.37M shares derived: sum of 3 quarters · filed 2015-08-03 | 2.49M shares derived: sum of 4 quarters · filed 2015-08-03 |
| 2015-03-31 | 1.80M shares 10-Q · filed 2015-05-01 | 1.98M shares derived: sum of 2 quarters · filed 2015-05-01 | 2.10M shares derived: sum of 3 quarters · filed 2015-05-01 | 4.90M shares derived: sum of 4 quarters · filed 2015-05-01 |
| 2014-12-31 | 183.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 301.30K shares derived: sum of 2 quarters · filed 2015-03-16 | 3.10M shares derived: sum of 3 quarters · filed 2015-03-16 | 3.28M shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 118.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 2.92M shares derived: sum of 2 quarters · filed 2014-10-31 | 3.09M shares 10-Q · filed 2014-10-31 | 3.12M shares derived: sum of 4 quarters · filed 2014-10-31 |
| 2014-06-30 | 2.80M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | 2.98M shares 10-Q · filed 2014-08-01 | 3.00M shares derived: sum of 3 quarters · filed 2014-08-01 | 3.48M shares derived: sum of 4 quarters · filed 2014-08-01 |
| 2014-03-31 | 175.00K shares 10-Q · filed 2014-05-09 | 197.90K shares derived: sum of 2 quarters · filed 2014-05-09 | 677.40K shares derived: sum of 3 quarters · filed 2014-05-09 | 1.56M shares derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | 22.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | 502.40K shares derived: sum of 2 quarters · filed 2014-03-07 | 1.39M shares derived: sum of 3 quarters · filed 2014-03-07 | 1.48M shares 10-K · filed 2014-03-07 |
| 2013-09-30 | 479.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 1.37M shares derived: sum of 2 quarters · filed 2013-11-08 | 1.46M shares 10-Q · filed 2013-11-08 | 1.46M shares derived: sum of 4 quarters · filed 2013-11-08 |
| 2013-06-30 | 886.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 980.40K shares 10-Q · filed 2013-08-09 | 980.40K shares derived: sum of 3 quarters · filed 2013-08-09 | 994.20K shares derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | 93.75K shares 10-Q · filed 2013-05-10 | 93.75K shares derived: sum of 2 quarters · filed 2013-05-10 | 107.55K shares derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 13.80K shares derived: sum of 2 quarters · filed 2013-03-18 | 1.01M shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 13.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | 1.01M shares 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | 997.95K shares 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |